PRODUCTS SOLD ON POWERPEPTIDES.CO.UK ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.

CJC-1295 (Without DAC) + Ipamorelin Peptide Blend

⚠️ PRODUCTS SOLD ON POWERPEPTIDES.CO.UK ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.

CJC-1295 (Without DAC) + Ipamorelin is a dual research peptide blend combining 5 mg of CJC-1295 (without DAC) with 10 mg of Ipamorelin in a single lyophilised vial. Designed for in vitro research into pulse-based GHRH and GHRP receptor pathways. ≥98% purity (HPLC certified).

  • CJC-1295 (Without DAC): 5 mg + Ipamorelin: 10 mg
  • Total peptide content: 15 mg
  • ≥98% purity (HPLC verified)

For laboratory research use only. Not for human or veterinary use.

£37.00

SKU: PP-CJCIPA-10
Brand: Power Peptides

⚠️ For laboratory research use only. Not for human or veterinary use.

View Certificate of Analysis (COA)
  • High-purity research-grade formulation
  • Independently analysed via HPLC & LC-MS
  • Batch-specific COA available
  • UK-based dispatch & tracking
🔬 HPLC Verified 📦 Batch Traceable 🚚 UK Dispatch 🔒 Secure Checkout
⚠️ IMPORTANT RESEARCH NOTICE
All products supplied by Power Peptides are research-grade reagents. Not for human consumption, medical, veterinary, or diagnostic use.

What is the CJC-1295 (Without DAC) + Ipamorelin Blend?

This peptide formulation combines CJC-1295 Without DAC (5 mg) with Ipamorelin (10 mg) in a single sterile lyophilised vial. Both peptides act on distinct receptor pathways: CJC-1295 (without DAC) for growth hormone-releasing hormone (GHRH) modulation, and Ipamorelin for selective ghrelin receptor activation. This synergistic combination is researched in vitro to explore peptide receptor interactions, investigational endocrinology, and pulsatile peptide dynamics.

Research Applications

  • Investigation of GHRH and GHRP receptor co-activation
  • Studies on pulsatile peptide signalling pathways
  • In vitro examination of peptide synergy
  • Metabolic and cellular signalling research

Key Features

  • Dual peptide blend: 5 mg CJC-1295 (Without DAC) + 10 mg Ipamorelin
  • Total peptide content: 15 mg
  • ≥98% purity (HPLC verified)
  • Designed exclusively for controlled laboratory use
  • Batch-specific Certificate of Analysis available

Specifications

Product Name CJC-1295 Without DAC + Ipamorelin Blend
Total Peptide Content 15 mg
Composition CJC-1295 (Without DAC) 5 mg + Ipamorelin 10 mg
Form Lyophilised peptide powder
Purity ≥98% (HPLC certified)
Appearance White to off-white powder
Solubility Soluble in bacteriostatic water
Storage (unopened) –20 °C, protected from light
Storage (after reconstitution) 2–8 °C; aliquoting recommended
Documentation Certificate of Analysis available upon request

Reconstitution & Handling

  • Reconstitute with bacteriostatic water
  • Gently swirl until fully dissolved; avoid agitation
  • For laboratory in vitro use only; not for in vivo analysis

Quality & Testing

This peptide blend is validated for identity and purity via high-performance liquid chromatography (HPLC) and mass spectrometry. Each batch is traceable and documented for research reproducibility.

Important Notice

For laboratory research use only. This product is not intended for human consumption, diagnostic use, therapeutic administration, or veterinary application.

CJC-1295 (Without DAC) + Ipamorelin Peptide Blend
£37.00